Evolution of the RebiSmart(®) Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis

BACKGROUND: The RebiSmart(®) electromechanical autoinjector supports people living with relapsing multiple sclerosis (MS) with their adherence to treatment with subcutaneous interferon beta-1a (sc IFN β-1a; Rebif(®)), a well-established and effective therapy. We report on the validation of the next-...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yu-Ting, Will, Tamara, Wickham, Charlotte, Boeree, Petra, Jack, Dominic, Keiser, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423595/
https://www.ncbi.nlm.nih.gov/pubmed/37581193
http://dx.doi.org/10.2147/PPA.S414151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423595/
https://www.ncbi.nlm.nih.gov/pubmed/37581193
http://dx.doi.org/10.2147/PPA.S414151

Ejemplares similares